cTnT was significantly predicted by age, gender, family history of heart disease (see Table I for definition), pulmonary hypertension, angina, diabetes, and use of ACE-I/ARBs, aldosterone antagonists and statins (P < 0.05), R2 = 0.299, n = 346. Here, TNNT2 is linked to pulmonary hypertension.